Quarterly Report • Jul 27, 2023
Quarterly Report
Open in ViewerOpens in native device viewer




Revenues increased by 11% in the second quarter and 1% excluding foreign exchange effects. The growth was driven by price increases of up to 30% for new users in selected markets implemented during 2023, improving blended ARPU by 6%, offset by a reduction in the number of subscribers of 5% compared to last year. The number of new subscribers increased in the second quarter compared to last year, which is a reversal of the trend of the prior three quarters that all saw a decline in new subscribers. During the second quarter, an optimisation program was launched to refocus resources to drive growth in the core product, while also reducing the cost base by an expected MSEK 25 on a yearly basis, in turn increasing the adjusted EBIT margin to 30%.
customers will get access to Sleep Cycle as part of their membership.
• At the annual general meeting on 8 May, the audit firm Öhrlings PricewaterhouseCoopers was elected as new auditor in Sleep Cycle. The meeting elected Mathias Høyer as new board member, while Lars Berg and Ödgärd Andersson declined being re-elected and were thanked for their service. Anne Broeng was elected new chairperson
• During an extraordinary general meeting on 26 July, it was decided to add an additional member to the board and to elect Sleep Cycle's founder and principal owner Maciej Drejak as new board member.
| GROUP KEY PERFORMANCE INDICATORS | Apr - Jun | Jan - Jun | Jan - Dec | ||
|---|---|---|---|---|---|
| TSEK | 2023 | 2022 | 2023 | 2022 | 2022 |
| Net sales | 58,233 | 52,503 | 114,680 | 102,593 | 213,271 |
| Net sales growth (%) | 10.9% | 19.0% | 11.8% | 19.1% | 16.6% |
| Currency-adjusted net sales growth (%) | 1.0% | 16.1% | 2.0% | 18.6% | 12.4% |
| Operating profit/loss | 12,734 | 12,793 | 23,824 | 25,536 | 44,110 |
| Operating margin (%) | 21.9% | 24.4% | 20.8% | 24.9% | 20.7% |
| Adjusted operating profit/loss | 17,267 | 12,793 | 28,655 | 25,536 | 46,912 |
| Adjusted operating margin (%) | 29.7% | 24.4% | 25.0% | 24.9% | 22.0% |
| Net profit | 10,313 | 10,102 | 19,386 | 20,196 | 34,976 |
| Operational key performance indicators | |||||
| Total subscriptions (Thousands) | 877 | 921 | 877 | 921 | 904 |
| ARPU (SEK) | 264 | 228 | 257 | 225 | 236 |
| Average number of employees (#) | 50 | 46 | 49 | 45 | 46 |
For definitions, justifications and derivations, see page 18.
During the second quarter, we launched an optimisation program to refocus on our core business. Sleep Cycle offers a valued consumer application, which historically has resulted in low acquisition costs and high customer loyalty, and we believe through continued investment in product development that we can add even more value and reach even more consumers. At the same time, the optimisation program allows us to free up resources resulting in a an expected reduction in costs of MSEK 25 on an annual basis.
During the second quarter we saw a stable development in the number of users with only a minor change from the first quarter. The total amount of users declined to 877k compared to the previous year, but I am very happy to see an increase in the inflow of new subscribers compared to the second quarter last year. This, combined with rising ARPU, shows that we are not only attracting more new customers, but are also doing this with higher revenue per user than previously. By continuously investing in innovative solutions and products that drive conversion, I am confident that we will soon see even stronger growth in sales and user base.
The adjusted operating profit for the period was MSEK 17.3, which is MSEK 4.5 higher than in the second quarter of the previous year. The result has mainly been affected by the optimisation programme we implemented to focus the operations, increase productivity and create room for continued product-driven growth. The measures, that incurred MSEK 4.5 in non-recurring items during the quarter, have been carried out according to plan, and total savings are expected to result in the operating margin exceeding 30% in the coming quarter. By prioritising investments in the core product, while also reducing additional initiatives, the effect on the user base is expected to be limited.
Sleep Cycle's success and profitability have historically been linked to low costs for customer acquisition. This is basically about us having an appreciated product that is given consistently high ratings by our users. With higher investments in the core products we create an even better user experience that affects the conversion and renewal rate, which creates growth in the user base. We also continue finetuning our marketing strategy and diversifying our distribution channels to reach more users.
Apple Watch is a growing platform and last year we launched the feature Auto Sleep Tracking on the platform, which was an important milestone for us. This feature makes using our product even easier, while it also provides us with more data points to use in our analyses for users. We have now been able to evaluate this service over the course of several months, and it has shown to be very appreciated. At the same time, the service has successfully contributed to us being able to deliver on our business targets as we see that customers are not just more active and also use the product more often, and for longer periods, but also that they are more loyal. The service has converted more than 7,000 users and we also see that the renewal rate among those who use the feature is clearly higher than for other users.
When we now enter the second half of the year, we do so with an enhanced organisation that is fully focused on increasing the appeal in our offer. During the coming quarter we are going to roll out several new features, updates with improvements and technical novelties linked to our patented sound analysis. We feel confident in our strategy and the way forward. The feedback we continuously receive from our users show that they appreciate what we do and that Sleep Cycle delivers value in many different ways. This bodes well!

Carl Johan Hederoth CEO Sleep Cycle AB
The higher margin is explained primarily by lower marketing costs and less staff.
Sleep Cycle is a leader in the development of AI-based sleep analysis. With more than two million users in over 150 countries, Sleep Cycle is one of the world's most used sleep services.
Our business is built on a subscription-based business model, which through advance payments and recurring income creates predictability and strong cash flow. As we offer an appreciated product that is based on many years of development, and for which the inflow of customers to a large part takes place organically, we have low costs for customer acquisition which gives high profitability. In combination with the costs for each new user being zero, our business becomes fully scalable.
AI and machine learning have revolutionised our ability to manage large amounts of data and to extract valuable information. By using advanced algorithms and technologies we can extract patterns and connections that were previously unknown and inaccessible.
Sleep Cycle analyses sound which by using a database with more than two billion nights gives users individual insights, advice and recommendations about their sleep. As the analysis is sound-based, even snoring, coughing, teeth grinding and other sounds that disturb sleep are captured and can provide us with further knowledge of health in a greater perspective.

Sleep Cycle's strategy for the coming year is to increase investment in data, AI and product development in order to increase our range, create user value and be able to grow through new acquisition channels. In order to reach our targets, our focus is set on offering a wider range of services and increased availability. We want to be present on platforms on which our target groups are and where our unique knowledge and interests in sleep creates value.

NEW DATA-DRIVEN FEATURES THAT GIVE USERS MORE INSIGHTS INTO SLEEP AND HEALTH.
SLEEP ANALYSIS
HEALTH MONITORING FLU
SYMPTOMS
SNORING
SLEEP APNEA TEETH GRINDING

NEW USERS VIA NEW PLATFORMS, PARTNERSHIPS AND CHANNELS.
PARTNERSHIPS
MORE PLATFORMS
NEW HARDWARE
Since all material activities in the group are conducted in the parent company, comments below refer to both the parent company and the group. For profit and cash flow, comparative figures refer to the corresponding period last year. For financial position, comparative figures refer to balance sheet items as of 31 December 2022.
The group's net sales in the second quarter amounted to tsek 58,233 (52,503), which is an increase of 10.9 (19.0) % compared to the previous year. The increase in sales is due mainly to the effect of the exchange rate as the swedish krona has weakened against most foreign currencies, primarily EUR and USD. Price adjustments implemented during 2022 have also contributed to higher revenue per user, but with a lower volume having contributed to a limited effect on total revenue. Currency-adjusted net sales growth was 1.0 (16.1)%. Average revenue per user (ARPU) increased by 16.0% and amounted to sek 264 (228).
The number of paying users was 877k (921k). The drop in the total number of users is due mainly to a lower acquisition rate of new customers resulting from a weaker market with fewer downloads and previously implemented price adjustments. The development in the number of users during the second quarter was relatively stable and the drop compared to the first quarter limited. The second quarter saw an increase in gaining new customers compared to the previous year, which may indicate a positive reverse in the trend in the development of volume from previous periods.
Operating profit amounted to TSEK 12,734 (12,793) and the margin was 21.9 (24.4) % in the second quarter. The underlying cost level remained at approximately the same level as the previous year but with the difference in operating profit resulting mainly from items affecting comparability in connection with the optimisation programme.
Adjusted operating profit was TSEK 17,267 (12,793) and adjusted margin was 29.7 (24.4) %. The items other external costs and personnel costs include costs affecting comparability of TSEK 83 and TSEK 4,450, respectively, related to the optimisation programme to save about MSEK 25 annually, while focusing the operations on product-driven growth. Cost-cutting measures involved reducing the number of employees, less purchasing of external services and lower investments in marketing. The measures are expected to lead to the operating margin in the coming quarter exceeding 30%. The measures have been implemented gradually and have, adjusted for items affecting comparability, had a positive effect on the cost level during the second half of the quarter.
Net financial income during the quarter amounted to TSEK 274 (-45) and tax on profit for the quarter amounted to SEK -2,695 (-2,646). Profit for the quarter amounted to TSEK 10,313 (10,102). Earnings per share before dilution amounted to SEK 0.51 (0.52) and after dilution to SEK 0.51 (0.51).
Cash flow from operating activities in the second quarter amounted to TSEK 19,049 (14,736). The change in cash flow from operating activities is due mainly to positive changes in the working capital.
Cash flow from investment activities amounted to TSEK -2,593 (-2,019) related to capitalized development expenses and the acquisition of tangible assets.
Cash flow from financing activities amounted to TSEK -142,936 (-376) in the quarter. The change relates to dividend from the financial year 2022 which was paid in the second quarter of 2023.
Cash flow for the quarter amounted to TSEK -126,481 (12,340) as a result of the dividend paid. The group's cash and cash equivalents amounted to TSEK 104,716 (202,515) at the end of the period.
The group's equity amounted to TSEK 38,277 as of 30 June. Opening balance on 1 January was TSEK 160,834.
Changes in turnover, profit, cash flow and financial position for the six-month period 2023 compared to the previous year are largely due to the same reasons as for the second quarter. Below you can see the development for the half-year with comments in case there are other reasons for the development than for the second quarter.
The group's net sales during the period amounted to TSEK 114,680 (102,593), which is an increase of 11.8 (19.1)% compared to the previous year. currency-adjusted net sales growth was 2.0 (18.6)%.
Operating profit amounted to TSEK 23,824 (25,536) and the margin was 20.8 (24.9)% in the period. Adjusted operating profit amounted to TSEK 28,655 (25,536) and the adjusted margin was 25.0 (24.9)%. The item other external costs includes items affecting comparability of TSEK 298 related to the public cash offer during 2022. Other external costs further include TSEK 83 and TSEK 4,450 in personnel costs related to the optimisation programme to save about MSEK 25 annually. Adjusted for the items above, the operating profit was in line with the previous year but improved thanks to a reduction in personnel in the second quarter (which resulted in items affecting comparability).
Net financial income during the period amounted to TSEK 636 (-59) and tax on net profit amounted to TSEK -5,075 (-5,281). Net profit amounted to TSEK 19,386 (20,196). Earnings per share before dilution amounted to SEK 0.96 (1.04) and after dilution to SEK 0.96 (1.01).
Cash flow from operating activities amounted to TSEK 21,029 (41,664) in the period.
Cash flow from investment activities amounted to TSEK -5,606 (-3,101) related to capitalized development expenses and the acquisition of tangible assets. The change is due primarily to investments related to moving to new offices and investments in the new application Sleep Cycle Kids.
Cash flow from financing activities amounted to TSEK -143,570 (-1,145) and relate to repayment of lease liabilities and dividend paid during 2023. The change compared to the previous year results from the dividend paid.
Cash flow for the period amounted to TSEK -128,147 (37,418). The group's cash and cash equivalents amounted to TSEK 104,716 (202,515) at the end of the period.
The group's equity amounted to TSEK 38,277 as of 30 June. Opening balance on 1 January was TSEK 160,834.
The average number of employees in the group for the quarter April to June 2023 was 50 (46) and for the period January to June 2023 it was 49 (45). The number of employees after reductions as part of the efficiency program was 39.
The group's overall risk management involves striving for minimal adverse effects on profit and position. Significant risks and uncertainties are described in the annual report for 2022. No events of significant importance have occurred during the period that affect or change the descriptions of the group's risks and their management.
The group's operations are essentially conducted in the parent company, which is why reference is made to the above information for the group.
Apart from transactions with senior executives in the capacity of their roles, there have been no transactions with related parties.
This report has not been reviewed by the company's auditors.
On 27 July at 9:30 AM, a presentation of Sleep Cycle's interim report for April-June 2023 will be held for shareholders, the media and other stakeholders. Participants will be able to follow the presentation via a webcast.
The company's share has been listed on Nasdaq Stockholm since 8 June 2021 under the ticker SLEEP. The share capital amounted to TSEK 563 on the balance sheet date.
| Number of | Corresponding number of sha |
Proportion of | |||
|---|---|---|---|---|---|
| Options program | options | res | total shares | Exercise rate | Exercise period |
| TO 2020 | 1,225 | 147,000 | 0.7% | 88.9 | 2023 |
| TO 2021 series 1 | 190,076 | 190,076 | 0.9% | 94.5 | 2024 |
| TO 2021 series 2 | 18,595 | 18,595 | 0.1% | 94.5 | 2025 |
| TO 2022 | 54,820 | 54,820 | 0.3% | 71.2 | 2025 |
| CEO LTIP | 340,909 | 340,909 | 1.7% | 241.2 | 2026 |
| Total | 605,625 | 751,400 | 3.7% |
| Owner | Number of shares |
Votes and capital |
|---|---|---|
| Maciek Drejak through company | 8,707,984 | 42.9% |
| Pierre Siri through company | 4,776,686 | 23.6% |
| Handelsbanken Microcap | 1,307,240 | 6.4% |
| Avanza Pension | 743,642 | 3.7% |
| Skandia Fonder | 714,285 | 3.5% |
| Petter Wallin | 691,394 | 3.4% |
| Nordnet Pensionsförsäkring | 605,233 | 3.0% |
| Lancelot Avalon | 400,000 | 2.0% |
| Cancerfonden (Swedish Cancer Society) | 291,882 | 1.4% |
| SEB Nanocap | 220,000 | 1.1% |
| Other | 1,819,217 | 9.0% |
| Total | 20,277,563 | 100% |
| Apr - Jun | Jan - Jun | Jan - Dec | ||||
|---|---|---|---|---|---|---|
| TSEK | Note | 2023 | 2022 | 2023 | 2022 | 2022 |
| OPERATING INCOME | ||||||
| Net sales | 4 | 58,233 | 52,503 | 114,680 | 102,593 | 213,271 |
| Other operating income | 51 | 208 | 67 | 398 | 529 | |
| OPERATING EXPENSES | ||||||
| Capitalized work for own account | 569 | 1,123 | 1,029 | 1,801 | 3,224 | |
| Platform fees | -13,034 | -12,367 | -25,676 | -24,264 | -49,741 | |
| Other external expenses | -12,344 | -13,572 | -29,172 | -25,445 | -63,383 | |
| Personnel costs | -18,319 | -13,652 | -32,970 | -26,858 | -54,201 | |
| Depreciation and write-downs of tangible and intangible assets |
-2,286 | -1,362 | -3,903 | -2,603 | -5,261 | |
| Other operating expenses | -135 | -86 | -230 | -86 | -329 | |
| Operating profit/loss | 12,734 | 12,793 | 23,824 | 25,536 | 44,110 | |
| FINANCIAL ITEMS | ||||||
| Financial income | 479 | - | 872 | 1 | 157 | |
| Financial expenses | -205 | -45 | -235 | -60 | -137 | |
| Profit before tax | 13,009 | 12,748 | 24,460 | 25,477 | 44,130 | |
| Tax on profit for the period | -2,695 | -2,646 | -5,075 | -5,281 | -9,155 | |
| Profit for the period attributable to the parent company's shareholders |
10,313 | 10,102 | 19,386 | 20,196 | 34,976 | |
| Other comprehensive income | - | - | - | - | - | |
| Comprehensive income for the period attributable to the parent company's shareholders |
10,313 | 10,102 | 19,386 | 20,196 | 34,976 | |
| Earnings per share before dilution, SEK | 0.51 | 0.52 | 0.96 | 1.04 | 1.77 | |
| Earnings per share after dilution, SEK | 0.51 | 0.51 | 0.96 | 1.01 | 1.74 | |
| Average number of shares outstanding for the period before dilution |
20,277,203 | 19,427,535 | 20,277,203 | 19,427,535 | 19,729,788 | |
| Average number of shares outstanding for the period after dilution |
20,277,203 | 19,919,146 | 20,277,203 | 19,948,780 | 20,056,591 |
| TSEK Note |
30/06/2023 | 30/06/2022 | 31/12/2022 |
|---|---|---|---|
| ASSETS | |||
| Intangible fixed assets | |||
| Capitalized expenses for development work | 11,669 | 6,476 | 9,595 |
| Patent | - | - | - |
| Total intangible assets | 11,669 | 6,476 | 9,595 |
| Tangible fixed assets | |||
| Right-of-use assets | 17,777 | 5,215 | 4,132 |
| Leasehold improvements | 825 | - | - |
| Equipment and computers | 1,997 | 1,173 | 1,468 |
| Total tangible assets | 20,599 | 6,388 | 5,601 |
| Financial assets | |||
| Other long-term receivables | 411 | 411 | 411 |
| Total financial assets | 411 | 411 | 411 |
| Deferred taxes | |||
| Deferred tax asset | 33 | 49 | 13 |
| Purple deferred taxes | 33 | 49 | 13 |
| Current assets | |||
| Trade receivables | 30,276 | 16,793 | 22,388 |
| Other receivables | 755 | 668 | 1,084 |
| Current tax assets | 3,023 | 3,780 | 1,474 |
| Prepaid expenses and accrued income | 31,768 | 28,509 | 27,943 |
| Cash and cash equivalents | 104,716 | 202,515 | 232,862 |
| Total current assets | 170,537 | 252,265 | 285,751 |
| TOTAL ASSETS | 203,249 | 265,589 | 301,371 |
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Share capital | 563 | 540 | 563 |
| Other capital contributions | - | 102,660 | 119,229 |
| Profit brought forward including | |||
| profit/loss for the year | 37,714 | 26,262 | 41,042 |
| Total equity attributable to shareholders in the parent company |
38,277 | 129,462 | 160,834 |
| Long-term liabilities | |||
| Lease liabilities | 13,854 | 3,251 | 2,623 |
| Total long-term liabilities | 13,854 | 3,251 | 2,623 |
| Current liabilities | |||
| Lease liabilities | 4,084 | 2,010 | 1,572 |
| Accounts payable - trade | 11,405 | 11,155 | 14,203 |
| Other liabilities | 3,689 | 2,944 | 2,889 |
| Accrued expenses and deferred income | 131,939 | 116,767 | 119,250 |
| Total current liabilities | 151,118 | 132,876 | 137,914 |
| TOTAL EQUITY AND LIABILITIES | 203,249 | 265,589 | 301,371 |
| Attributable to shareholders of the parent company | ||||
|---|---|---|---|---|
| TSEK | 30/06/2023 | 30/06/2022 | 31/12/2022 | |
| Opening balance | 160,834 | 108,898 | 108,898 | |
| Net profit | 19,386 | 20,196 | 34,976 | |
| Dividend | -141,943 | - | - | |
| Option premiums | - | 368 | 368 | |
| New share issues after issue expenses | - | - | 16,593 | |
| Closing balance | 38,277 | 129,462 | 160,834 | |
| Apr - Jun | Jan - Jun | Jan - Dec | |||
|---|---|---|---|---|---|
| TSEK Note |
2023 | 2022 | 2023 | 2022 | 2022 |
| Cash flow from operating activities | |||||
| Operating profit/loss | 12,734 | 12,793 | 23,824 | 25,536 | 44,110 |
| Adjustments for non-cash items, etc.: | |||||
| Depreciation and write-downs | 2,286 | 1,362 | 3,903 | 2,603 | 5,261 |
| Interest received | 479 | - | 872 | 1 | 157 |
| Interest paid | -205 | -45 | -235 | -60 | -137 |
| Tax paid | -3,032 | -2,994 | -6,644 | -4,048 | -5,525 |
| Cash flow from operating activities before changes in working capital |
12,263 | 11,117 | 21,720 | 24,032 | 43,866 |
| Change in working capital | |||||
| Change in operating receivables | 11,806 | 5,983 | -11,383 | 3,136 | -2,309 |
| Change in operating liabilities | -5,020 | -2,364 | 10,693 | 14,496 | 19,971 |
| Cash flow from operating activities | 19,049 | 14,736 | 21,029 | 41,664 | 61,528 |
| Investment activities | |||||
| Capitalization of development expenses | -1,626 | -1,800 | -3,906 | -2,766 | -6,917 |
| Acquisition of tangible assets | -967 | -219 | -1,699 | -335 | -852 |
| Cash flow from investment activities | -2,593 | -2,019 | -5,606 | -3,101 | -7,769 |
| Financing activities | |||||
| Repayment of lease liabilities | -993 | -754 | -1,627 | -1,512 | -2,899 |
| Repaid option premiums | - | - | - | -11 | -11 |
| Option premiums received | - | 378 | - | 378 | 378 |
| Dividend | -141,943 | - | -141,943 | - | - |
| New share issues | - | - | - | - | 16,538 |
| Cash flow from financing activities | -142,936 | -376 | -143,570 | -1,145 | 14,006 |
| Cash flow for the period | -126,481 | 12,340 | -128,147 | 37,418 | 67,765 |
| Cash and cash equivalents at the beginning of the period |
231,196 | 190,174 | 232,862 | 165,508 | 165,508 |
| Reclassification of liquid assets | - | - | - | -411 | -411 |
| Cash and cash equivalents at the end of the period | 104,716 | 202,515 | 104,716 | 202,515 | 232,862 |
| Apr - Jun | Jan - Jun | Jan - Dec | |||
|---|---|---|---|---|---|
| TSEK Note |
2023 | 2022 | 2023 | 2022 | 2022 |
| OPERATING INCOME | |||||
| Net sales | 58,233 | 52,503 | 114,680 | 102,593 | 213,271 |
| Other operating income | 51 | 208 | 67 | 398 | 529 |
| Capitalized work for own account | 569 | 1,123 | 1,029 | 1,801 | 3,224 |
| OPERATING EXPENSES | |||||
| Platform fees | -13,034 | -12,367 | -25,676 | -24,264 | -49,741 |
| Other external expenses | -13,542 | -14,370 | -31,028 | -27,011 | -66,413 |
| Personnel costs | -18,319 | -13,652 | -32,970 | -26,858 | -54,201 |
| Depreciation and write-downs of tangible and intangible assets |
-1,200 | -598 | -2,178 | -1,086 | -2,340 |
| Other operating expenses | -135 | -86 | -230 | -86 | -329 |
| Operating profit/loss | 12,623 | 12,760 | 23,694 | 25,486 | 44,000 |
| RESULT FROM FINANCIAL ITEMS | |||||
| Interest income and similar income | 479 | - | 872 | 1 | 157 |
| Profit before tax | 13,102 | 12,760 | 24,566 | 25,487 | 44,158 |
| Tax on profit for the period | -2,715 | -2,649 | -5,095 | -5,282 | -9,159 |
| Net profit | 10,387 | 10,111 | 19,471 | 20,205 | 34,999 |
| COMPREHENSIVE INCOME FOR THE PERIOD | 10,387 | 10,111 | 19,471 | 20,205 | 34,999 |
Since the parent company has no items are recognized as other comprehensive income, total comprehensive income for the period is equal to profit for the period.
| TSEK Note |
30/06/2023 | 30/06/2022 | 31/12/2022 |
|---|---|---|---|
| ASSETS Fixed assets |
|||
| Intangible fixed assets | |||
| Capitalized expenses for development work | 11,669 | 6,476 | 9,595 |
| Patent | - | - | - |
| Total intangible assets | 11,669 | 6,476 | 9,595 |
| Tangible fixed assets | |||
| Leasehold improvements | 825 | - | - |
| Equipment and computers | 1,997 | 1,173 | 1,468 |
| Total tangible assets | 2,822 | 1,173 | 1,468 |
| Financial assets | |||
| Participations in group companies | 50 | 50 | 50 |
| Deferred tax asset | - | 39 | - |
| Other long-term receivables | 411 | 411 | 411 |
| Total financial assets | 461 | 500 | 461 |
| Total fixed assets | 14,953 | 8,149 | 11,524 |
| Current assets | |||
| Current receivables | |||
| Trade receivables | 30,276 | 16,793 | 22,388 |
| Other receivables | 755 | 668 | 1,084 |
| Current tax assets | 3,023 | 3,780 | 1,474 |
| Prepaid expenses and accrued income | 31,768 | 28,509 | 27,943 |
| Total current receivables | 65,821 | 49,751 | 52,889 |
| Current investments | |||
| Other current investments | 75,000 | - | - |
| Total current investments | 75,000 | - | - |
| Cash and bank balances | 29,607 | 202,398 | 232,746 |
| Total current assets | 170,428 | 252,148 | 285,635 |
| TOTAL ASSETS | 185,381 | 260,297 | 297,160 |
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Restricted equity | |||
| Share capital | 563 | 540 | 563 |
| Fund for development expenditures | 11,669 | 6,476 | 9,595 |
| Total restricted equity | 12,232 | 7,015 | 10,158 |
| Non-restricted equity | |||
| Share premium reserve | - | 102,660 | 119,229 |
| Accumulated profit or loss | 6,643 | -449 | -3,568 |
| Net profit | 19,471 | 20,205 | 34,999 |
| Total non-restricted equity | 26,114 | 122,416 | 150,660 |
| Total equity | 38,346 | 129,431 | 160,818 |
| Current liabilities | |||
| Accounts payable - trade | 11,405 | 11,155 | 14,203 |
| Other liabilities | 3,689 | 2,944 | 2,889 |
| Accrued expenses and deferred income | 131,939 | 116,767 | 119,250 |
| Total current liabilities | 147,034 | 130,866 | 136,341 |
| TOTAL EQUITY AND LIABILITIES | 185,381 | 260,297 | 297,160 |
The address of the head office is Drakegatan 10, 412 50 Gothenburg. Sleep Cycle drives the development of one of the world's most widely used sleep platforms. Sleep Cycle's sleep solutions help users fall asleep more easily, measure sleep habits and improve sleep, plus with their large sleep database contribute to improving sleep habits and increased sleep awareness worldwide. The business is mainly conducted in the parent company. The parent company's participations in group companies as of 30 June 2023 consist of the wholly-owned subsidiary Sleep Cycle Sverige AB (559278–9688).
Sleep Cycle's interim report for January-June 2023 was approved for publication on 27 July, following a decision by the board of directors on 26 July 2023.
The consolidated financial statement for Sleep Cycle AB has been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the EU, the Swedish Annual Accounts Act (ÅRL) and The Swedish Financial Reporting Board
RFR 1 "Supplementary accounting rules for groups". The parent company's financial statements are prepared in accordance with the Annual Accounts Act and RFR 2, "Financial reporting for legal entities".
This interim report has been prepared in accordance with IAS 34 "Interim Reporting". Disclosures pursuant to IAS 34 are provided in both notes and elsewhere in the interim report.
The accounting policies and calculation methods applied are in accordance with those described in the annual report for 2022. New standards and interpretations that have come into force as of 1 January 2023 have not had any effect on the group's or the parent company's financial statements for the interim period.
Sleep Cycle's CEO, as the highest executive decision maker, follows up and analyses the results and financial position for the group as a whole. The CEO does not follow up on a result lower than the group as a whole. Thus the CEO also decides on the distribution of resources and make strategic decisions based on the group as a whole. Based on the above analysis, which is itself based on IFRS 8, it is concluded that the Sleep Cycle-group consists of a single reporting segment.
| Apr - Jun | Jan - Jun | Jan - Dec | |||
|---|---|---|---|---|---|
| TSEK | 2023 | 2022 | 2023 | 2022 | 2022 |
| Subscription revenue | 58,108 | 52,459 | 114,365 | 102,330 | 212,534 |
| Other income | 126 | 45 | 316 | 262 | 737 |
| Total | 58,233 | 52,503 | 114,680 | 102,593 | 213,271 |
| TSEK | 30/06/2023 | 30/06/2022 | 31/12/2022 |
|---|---|---|---|
| Financial assets valued at amortised cost | |||
| Trade receivables | 30,276 | 16,793 | 22,388 |
| Other receivables | 1,167 | 1,079 | 1,496 |
| Accrued income | 265 | - | - |
| Cash and cash equivalents | 104,716 | 202,515 | 232,862 |
| Total financial assets | 136,423 | 220,387 | 256,746 |
| Financial liabilities valued at an amortised cost | |||
| Lease liabilities | 19,724 | 5,845 | 4,381 |
| Accounts payable - trade | 11,405 | 11,155 | 14,203 |
| Other current liabilities | 2,390 | 2,645 | 5,849 |
| Total financial liabilities | 33,519 | 19,646 | 24,433 |
Sleep Cycle does not have any financial instruments that are valued and recognized at fair value. For all financial assets and liabilities, the carrying amount shown above is considered to be a reasonable approximation of fair value.
Sleep Cycle applies the ESMA guidelines for alternative performance measures. This report presents certain financial performance measures, including alternative performance measures, that are not defined under IFRS. The Company believes that these ratios are an important complement, as they allow a better evaluation of the Company's financial trends. These financial performance measures should not be viewed
in isolation or be considered to replace the performance indicators that have been prepared in accordance with IFRS. In addition, such performance measures as Sleep Cycle has defined them should not be compared with other performance measures with similar names used by other companies. This is because the above-mentioned performance measures are not always defined in the same manner, and other companies may calculate them differently.
| Key performance indicator | Definition | Reason for alternative performance indicator |
|---|---|---|
| Net sales growth | Change in net sales compared to the same period last year. |
The measure shows the company's growth in net sales compared to the same period last year. |
| Currency-adjusted net sales growth |
Defined as net sales for the year divided by the previous year's net sales converted to the year's average exchange rates for the company's main foreign exchange exposures (USD, EUR, JPY, GBP, AUD and CAD). |
Used to measure the company's underlying net sales growth cleared for currency effects. |
| Operating profit/loss | Operating profit/loss before interest and tax | The operating profit/loss is used to understand the company's earning capacity |
| Operating margin | Operating profit/loss as a percentage of the company's net sales. |
Operating margin is an indication of the company's earning capacity in relation to net sales. |
| Items affecting comparability |
Non-recurring items which are not part of the normal operations, and are therefore affecting comparability between different periods. Refers to costs related to the IPO 2021, public cash offer 2022 and cost savings 2023. |
The measure is used to understand the company's development and comparison between the years. |
| Adjusted operating profit/loss |
Operating profit/loss adjusted for items affecting comparability. |
Adjusted operating profit/loss is used to understand the company's earning capacity cleared for items affecting comparability. |
| Adjusted operating margin | Adjusted operating profit/loss as a percentage of the company's net sales. |
Adjusted operating margin is used to understand the company's earning capacity adjusted for items affecting comparability. |
| Total subscriptions | Total number of users at the end of the period (Closing Balance). |
The measure indicates how many users the company has at the end of the period. |
| ARPU | Average annual subscription revenue per subscriber during the period. Quarter and period count up to full years. |
The measure indicates the company's subscription revenue per subscription on average during the period. |
The table below derives the calculation of alternative key ratios that are not defined under IFRS or where the calculation is not shown in another table in this report.
| Net sales growth and currency-adjusted net sales growth |
Apr - Jun | Jan - Jun | Jan - Dec | ||
|---|---|---|---|---|---|
| TSEK | 2023 | 2022 | 2023 | 2022 | 2022 |
| Net sales previous period | 52,503 | 44,128 | 102,593 | 86,138 | 182,937 |
| Net sales current period | 58,233 | 52,503 | 114,680 | 102,593 | 213,271 |
| Net sales growth | 10.9% | 19.0% | 11.8% | 19.1% | 16.6% |
| Currency-adjusted net sales previous period | 57,635 | 45,206 | 112,470 | 86,482 | 189,743 |
| Net sales current period | 58,233 | 52,503 | 114,680 | 102,593 | 213,271 |
| Currency-adjusted net sales growth | 1.0% | 16.1% | 2.0% | 18.6% | 12.4% |
| Operating profit/loss and operating margin | Apr - Jun | Jan - Jun | Jan - Dec | ||
|---|---|---|---|---|---|
| TSEK | 2023 | 2022 | 2023 | 2022 | 2022 |
| Net sales | 58,233 | 52,503 | 114,680 | 102,593 | 213,271 |
| Other operating income | 51 | 208 | 67 | 398 | 529 |
| Work performed by the company for its own use and capitalised |
569 | 1,123 | 1,029 | 1,801 | 3,224 |
| Platform fees | -13,034 | -12,367 | -25,676 | -24,264 | -49,741 |
| Other external expenses | -12,344 | -13,572 | -29,172 | -25,445 | -63,383 |
| Personnel costs | -18,319 | -13,652 | -32,970 | -26,858 | -54,201 |
| Depreciation and write-downs of tangible and intangible assets |
-2,286 | -1,362 | -3,903 | -2,603 | -5,261 |
| Other operating expenses | -135 | -86 | -230 | -86 | -329 |
| Operating profit/loss | 12,734 | 12,793 | 23,824 | 25,536 | 44,110 |
Operating margin 21.9% 24.4% 20.8% 24.9% 20.7%
| Adjusted operating profit/loss and adjusted operating margin |
Apr - Jun | Jan - Jun | |||
|---|---|---|---|---|---|
| TSEK | 2023 | 2022 | 2023 | 2022 | 2022 |
| Operating profit/loss | 12,734 | 12,793 | 23,824 | 25,536 | 44,110 |
| Items affecting comparability External consultants |
-83 | - | -381 | - | -2,802 |
| Personnel costs | -4,450 | - | -4,450 | - | - |
| Total items affecting comparability | -4,533 | - | -4,831 | - | -2,802 |
| Adjusted operating profit/loss | 17,267 | 12,793 | 28,655 | 25,536 | 46,912 |
| Adjusted operating margin | 29.7% | 24.4% | 25.0% | 24.9% | 22.0% |
| ARPU | Apr - Jun | Jan - Jun | Jan - Dec | |||
|---|---|---|---|---|---|---|
| TSEK | 2023 | 2022 | 2023 | 2022 | 2022 | |
| Subscription revenue | 58,108 | 52,459 | 114,365 | 102,330 | 212,534 | |
| Number of subscriptions previous period (thousands) | 881 | 920 | 904 | 901 | 901 | |
| Number of subscriptions current period (thousands) | 877 | 921 | 877 | 921 | 904 | |
| ARPU (SEK) | 264 | 228 | 257 | 225 | 236 |
The Board of Directors and the Chief Executive Officer certify that this interim report provides a fair view of the parent company's and the group's operations, position and result and describes material risks and uncertainties facing the parent company and the companies included in the group.
Gothenburg, 26 July 2023
Anne Broeng Chairperson of the board
Rasmus Järborg Board member
Olof Nilsson Board member
Mathias Høyer Board member
Maciej Drejak Board member
Carl Johan Hederoth Chief Executive Officer
For further information, please contact:
CARL JOHAN HEDEROTH, CEO Tel: +46 72-164 62 75 email: [email protected]
PER ANDERSSON, CFO Tel: +46 70-939 53 27 email: [email protected]
SLEEP CYCLE AB Corp. ID No. 556614-7368, Drakegatan 10, 412 50 Gothenburg www.sleepcycle.com
SLEEP CYCLE - INTERIM REPORT APR-JUN 2023 22
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.